Esa Pitkänen
@epitkanen.bsky.social
📤 52
📥 179
📝 6
FIMM-EMBL Group Leader at
@fimm-uh.bsky
.social |
@mlbiomed.bsky
.social | mlbiomed.net
reposted by
Esa Pitkänen
Institute for Molecular Medicine Finland (FIMM)
2 months ago
Upcoming FIMM dissertation! 📢 MSc Veera Timonen from
@epitkanen.bsky.social
's group will defend her doctoral dissertation "Multimodal investigation of hematological features in healthy blood donors"
@helsinki.fi
on 27 March at 13:00. Welcome! 🔗
tapahtumat.helsinki.fi/en-FI/page/6...
0
1
1
Our new preprint: dual-task learning in >17k cancer WGS. Somatic variant models can transfer across datasets, but dataset shift strongly affects performance. Cross-cohort validation is essential.
www.medrxiv.org/content/10.6...
@fimm-uh.bsky.social
@mlbiomed.bsky.social
loading . . .
Pan-cancer tumour classification and risk stratification from whole-genome somatic variants via dual-task representation learning
Tumour typing from whole-genome sequencing is increasingly accurate, yet molecular subtyping from somatic variants remains challenging because of tumour heterogeneity and inconsistent clinical annotat...
https://www.medrxiv.org/content/10.64898/2026.03.02.26347318v1
3 months ago
1
3
2
reposted by
Esa Pitkänen
Nordic EMBL Partnership for Molecular Medicine
5 months ago
📢As part of the Nordic EMBL Partnership for Molecular Medicine,
@fimm-uh.bsky.social
is now recruiting doctoral researchers in the FIMM-EMBL International PhD Programme.
tinyurl.com/553jzfuy
Deadline for application February 6, 2026 👇
loading . . .
FIMM-EMBL International PhD Programme | HiLIFE – Helsinki Institute of Life Science | University of Helsinki
As part of the Nordic EMBL Partnership for Molecular Medicine, outstanding doctoral researchers are recruited to the institute-level rotation programme through the annual call. The recruited doctoral ...
https://tinyurl.com/553jzfuy
1
5
3
Grateful to
@syopasaatio.bsky.social
and donors for supporting our work at
@mlbiomed.bsky.social
! Thanks to this grant, we can develop new computational approaches for multimodal precision oncology.
@fimm-uh.bsky.social
add a skeleton here at some point
6 months ago
0
6
0
Excited to share our latest pre-print on profiling DNA adducts with nanopore sequencing! This study was led by Yrjö Koski, who developed a computational toolkit called IonStats, and identified several compound-specific effects caused by genotoxic compounds.
www.biorxiv.org/content/10.1...
loading . . .
Compound-specific DNA adduct profiling with nanopore sequencing and IonStats
Covalently bound DNA adducts are mutation precursors that contribute to aging and diseases such as cancer. Accurate detection of adducts in the genome will shed light on tumorigenesis. Commonly used a...
https://www.biorxiv.org/content/10.1101/2025.10.31.685820v1
7 months ago
3
2
2
you reached the end!!
feeds!
log in